GPOH Phase I/II Network SELECT Southwest
The GPOH ReSearch NEtwork EarLy PhasE Clinical Trials Southwest Germany (SELECT Southwest) promotes the access to innovative therapies in early clinical trials for children with malignancies in the southwest region of Germany
Powerful network, independent partners
Our Network unites 13 independent institutions for pediatric hematology
and oncology, all members of the GPOH. This powerful network guarantees a
smooth exchange and rapid transfer of knowledge between all members.
Central point of contact for our partners from science and industry is our coordination office. All requests will be forwarded to the network. Here, all requests are forwarded to our network, the exchange of information and expertise between the individual partners is supported and network activities are centrally managed. On our website we inform you about all open trials in the network..
Structure / Governance
The Phase I/II Board represents the leading committee of the Network SELECT. The board is composed of one representative of each participating center, always physicians experienced in the conduction of phase I/II clinical trials.
In regular meetings and telephone conferences the Phase I/II Board discusses new clinical trial requests: The Board nominates a spokeperson and a deputy for a time period of two years. Currently the spokeperson of the Network SELECT Southwest is Prof. Dr. Olaf Witt, Heidelberg, deputy Prof. Dr. Christine Mauz-Körholz, Giessen.
Contacts
Using our contact list, you can find the contact details of the
responsible persons of all centers of the network as well as the contact
persons for our open clinical trials.
Ongoing Clinical Trials
In our comprehensive study directory you will find an overview of all ongoing,
current and planned, studies. In addition, contacts and further information about
the respective clinical trial.
Accelerating the set-up of clinical trials
- single contact point ("One-stop-shop") for all sponsors
- professional phase I/II network structures
- clear presentation of currently active clinical trials
- well educated physicians and study nurses
- compliance with ICH-GCP standards